ArticleJournal for immunotherapy of cancer2026

Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer.

Wenxin Lian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.